The STING pathway targeting technologies - Roots Analysis
The STING pathway targeting technologies - Roots Analysis
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy.

Roots Analysis is pleased toannounce the publication of its recent study, titled, “STINGPathway Targeting Therapeutics and Technologies,2020-2030.


The report features an extensive study of the current marketlandscape and future potential of these therapeutics and affiliatedtechnologies, over the next decade. This study focuses specifically on smallmolecule STING modulators. The report features an in-depth analysis,highlighting the diverse capabilities of stakeholders engaged in this domain.In addition to other elements, the study includes:

§ A detailed assessmentof the current market landscape of therapeutics targeting STING Pathway. 

§ A detailed assessmentof the current market landscape of various technology platforms that are beingactively used for the development of STING modulators.

§ Detailed profiles ofdevelopers of therapeutics targeting STING pathway (shortlisted on thebasis of phase of development of pipeline products).

§ An in-depth analysisof more than 280 grants that have been awarded to research institutes engagedin STING pathway targeting therapeutics-related projects.

§ An analysis of theinitiatives of big pharma players engaged in this domain.

§ An analysis of thestart-ups / small players (established in the last ten years, less than 50employees) engaged in the development of STING pathway targetingtherapeutics.

§ A detailedpublication analysis of more than 300 peer-reviewed, scientific articles thathave been published during the period 2019 - Q1 2020.

§ An analysis of thepartnerships that have been established in this domain, in the recent past.

§ An analysis of theinvestments made in this domain.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

§ Types of Payment

§ Upfront Payments

§ Milestone Payments


§ Type of STINGModulator

§ Agonist

§ Antagonist


§ Key TherapeuticArea(s)

§ Oncological Disorders

§ InflammatoryDisorders

§ Infectious Diseases

§ Others


§ Route ofAdministration

§ Intratumoral

§ Intravenous

§ Oral

§ Subcutaneous

§ Others


§ Type of Molecule

§ Non-nucleotide

§ Cyclic Dinucleotide

§ Live Biotherapeutics

§ Oncolytic Peptides

§ Synthetic Peptides

§ Others


§ Key GeographicalRegions

§ North America

§ Europe

§ Asia-Pacific


Keycompanies covered in the report

§ Aduro Biotech

§ Bristol Myers Squibb

§ Eisai

§ GlaxoSmithKline

§ ImmuneSensor Therapeutics

§ Merck

§ Noxopharm

§ Spring Bank Pharmaceuticals

§ Synlogic


Formore information please click on the following link:


Other RecentOfferings

1.       Nuclear Medicine andRadiopharmaceuticals Manufacturing Market, 2020-2030

2.    GlobalPsychedelic Therapeutics Market by Type ofPsychedelic Substance (Ketamine, Psilocybin, MDMA and Others), by Origin(Natural and Synthetic), by Type of Therapy (Monotherapy, Combination andOthers), by Route of Administration (Oral, Intravenous, Intranasal and Others)and by Key Geographies (North America, Europe and Asia- Pacific and rest of theworld): Industry Trends and Global Forecasts, 2020-2030

3.    EndocannabinoidSystem Targeted Therapeutics Market, 2020-2030


About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at


Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415